A study led by Archie Bleyer, M.D., finds the prevalence of firearms, not mental illness, is what's driving gun deaths in U.S.

In response to the largest Oregon measles outbreak in more than 30 years, Ben Hoffman, M.D., issues a warning about the dangers to children younger than 5.

Following the U.S. Surgeon General’s recent advisory on parental stress as a public health issue, Marlo McIlraith, M.D., shares insight on how parents can deal with stress and find support.

Oregon is experiencing its largest measles outbreak in more than 30 years, and health officials are urging families to stay current on vaccines. Ben Hoffman, M.D., says, “Vaccination is a safe, simple and highly effective way to help keep your kids healthy and reduce the spread of disease within our community. Routine childhood vaccinations, including the two-shot series to protect against measles, are especially crucial as kids head back to school.”

In a long-form video interview with Sharing Progress in cancer care, Brian Druker, M.D., discusses his career, the development of the drug Gleevec, and the future of cancer research and care.

Oregon is experiencing its largest measles outbreak in more than 30 years, and health officials are urging families to stay current on vaccines. Ben Hoffman, M.D., says, “Vaccination is a safe, simple and highly effective way to help keep your kids healthy and reduce the spread of disease within our community. Routine childhood vaccinations, including the two-shot series to protect against measles, are especially crucial as kids head back to school.”

Oregon is experiencing its largest measles outbreak in more than 30 years, and health officials are urging families to stay current on vaccines. Ben Hoffman, M.D., says, “Vaccination is a safe, simple and highly effective way to help keep your kids healthy and reduce the spread of disease within our community. Routine childhood vaccinations, including the two-shot series to protect against measles, are especially crucial as kids head back to school.”

An OHSU study finds gene therapy for sickle cell disease has become substantially more unaffordable, jeopardizing patient access, especially among the 50,000 people with the disease enrolled in Medicaid.

The OHSU Knight Cancer Institute has enrolled its first subject in a clinical trial that tests the safety, tolerability and best dose of iadademstat when administered with the standard-of-care venetoclax and azacitidine in patients with newly diagnosed AML. Study lead Curis Lachowiez, M.D., says, “Given the activity observed with LSD1 inhibition in combination with azacitidine in AML, testing a triplet combination, including iadademstat with the highly active backbone of azacitidine+venetoclax, is the logical next step to hopefully improve outcomes of patients living with AML, if proven to be safe and active”: Globe Newswire press release picked up by outlets across the country.

In a ProPublica story about seeking mental health care, experts recommend patients reach out directly to a practitioner to verify whether they are included in their health network. Jane Zhu, M.D., says, “Verify, verify, verify. Accuracy in behavioral health provider directories is akin to a coin flip.”